Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women
- Status
- COMPLETED
- Phase
- NA
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE3
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE3
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Letrozole in Patients With Ovarian Tumors
- Status
- TERMINATED
- Phase
- PHASE2
PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE
- Status
- TERMINATED
- Phase
- PHASE2
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Letrozole Versus Clomifene Citrate for Ovulation Induction
- Status
- COMPLETED
- Phase
- PHASE4
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
- Status
- TERMINATED
- Phase
- PHASE2
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3